The health consequences of human trafficking and exploitation are sufficiently prevalent and damaging that they comprise a public health problem of global magnitude. This PLOS Collection offers…

PLOS ONE is proud to publish the Health Inequities and Disparities Collection. Launched in September 2019, this Call for Papers welcomed articles on all relevant disciplines in the field of public…

While regulation of medicines is a key pillar of any health system assuring access to quality medicines, an unoptimized regulatory system is a barrier to access. Over the last 8 years the East African…

In 2014, the EU funded a COST Action that brought together over 120 scientists, practitioners, activists and policy makers from 34 countries, to advance research and practice in an area of great…

At PLOS Pathogens we publish outstanding research on pathogenic organisms including bacteria, fungi, parasites, prions and viruses. Each year, we celebrate the impact our authors have had and share…

With recent opportunities to test combinations of new and repurposed drugs for the treatment of TB, new questions arise for optimal clinical trial design. To address these, in March 2018 WHO organized…

PLOS ONE is excited to publish a Collection on the early diagnosis and treatment of Alzheimer's disease. As the aging population continues to grow, the prevalence of Alzheimer’s disease is…

Economic Cases for NCD Prevention and Control expands the evidence base on the economic burden of noncommunicable diseases (NCDs) and the impact of NCD prevention and control programs globally. This…

Soil-transmitted helminths infect an estimated 1.45 billion people globally. The current WHO strategy for controlling STH is based on controlling morbidity via mass drug administration of medications…

High quality health care will be critical to attaining the Sustainable Development Goals in low- and middle income countries. However, little is known on levels of quality and its distribution within…